scPharmaceuticals (SCPH)
(Delayed Data from NSDQ)
$5.31 USD
+0.20 (3.91%)
Updated Sep 12, 2024 03:59 PM ET
After-Market: $5.30 -0.01 (-0.19%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for scPharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -54.81 | -36.84 | -28.03 | -32.21 | -33.00 |
Depreciation/Amortization & Depletion | 0.02 | 0.47 | 0.44 | 0.40 | 0.36 |
Net Change from Assets/Liabilities | -6.32 | -0.35 | -2.60 | 1.45 | 0.35 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.86 | 2.14 | 3.04 | 2.67 | 1.84 |
Net Cash From Operating Activities | -59.24 | -34.58 | -27.15 | -27.69 | -30.44 |
Property & Equipment | -0.04 | -0.02 | -0.01 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 20.01 | -45.84 | 32.14 | -33.46 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 19.97 | -45.86 | 32.13 | -33.46 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.35 | 46.69 | 0.05 | 50.92 | 0.06 |
Issuance (Repayment) of Debt | 0.00 | 29.80 | -2.50 | 0.00 | 9.56 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 14.50 | 0.74 | -0.08 | 9.42 | 3.97 |
Net Cash from Financing Activities | 14.85 | 77.23 | -2.53 | 60.35 | 13.59 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -24.43 | -3.21 | 2.45 | -0.81 | -16.85 |
Cash at Beginning of Period | 71.24 | 74.45 | 72.00 | 72.81 | 89.66 |
Cash at End of Period | 46.81 | 71.24 | 74.45 | 72.00 | 72.81 |
Diluted Net EPS | -1.42 | -1.30 | -1.02 | -1.31 | -1.77 |
Fiscal Year End for scPharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -31.20 | -14.11 | -54.81 | -41.00 | -25.36 |
Depreciation/Amortization & Depletion | 0.10 | 0.05 | 0.02 | 0.49 | 0.21 |
Net Change from Assets/Liabilities | -8.94 | -2.48 | -6.32 | -5.81 | -6.54 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.11 | -1.16 | 1.86 | 2.23 | 1.06 |
Net Cash From Operating Activities | -37.93 | -17.70 | -59.24 | -44.09 | -30.64 |
Property & Equipment | 0.00 | 0.00 | -0.04 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 29.32 | 29.32 | 20.01 | -6.50 | 16.43 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 29.32 | 29.32 | 19.97 | -6.50 | 16.43 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.18 | 0.18 | 0.35 | 0.17 | 0.10 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.12 | -0.17 | 14.50 | 14.21 | 14.21 |
Net Cash from Financing Activities | 0.30 | 0.02 | 14.85 | 14.38 | 14.32 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -8.31 | 11.63 | -24.43 | -36.20 | 0.11 |
Cash at Beginning of Period | 46.81 | 46.81 | 71.24 | 71.24 | 71.24 |
Cash at End of Period | 38.50 | 58.45 | 46.81 | 35.04 | 71.35 |
Diluted Net EPS | -0.44 | -0.36 | -0.35 | -0.41 | -0.36 |